Endovascular Treatment of Medium-Vessel-Occlusion Strokes.
Summary
Endovascular Treatment of Medium-Vessel-Occlusion Strokes. Original Article Abstract Background Endovascular thrombectomy for acute ischemic stroke due to medium-vessel occlusion has had varying results across trials. Whether thrombectomy improves functional outcomes in patients with medium-vessel occlusion and moderate-to-severe deficits is unclear. Methods We conducted an open-label, randomized trial with blinded outcome assessment at 48 centers in China. Eligible patients were adults
Content
# Endovascular Treatment of Medium-Vessel-Occlusion Strokes.
*Original Article*
# Abstract
## Background
Endovascular thrombectomy for acute ischemic stroke due to
medium-vessel occlusion has had varying results across trials. Whether
thrombectomy improves functional outcomes in patients with medium-vessel
occlusion and moderate-to-severe deficits is unclear.
## Methods
We conducted an open-label, randomized trial with blinded outcome
assessment at 48 centers in China. Eligible patients were adults who presented
within 24 hours after the onset of a moderate-to-severe stroke (National
Institutes of Health Stroke Scale [NIHSS] score, ā„6; scale, 0 to 42, with higher
scores indicating greater neurologic deficits) due to occlusion of a medium
vessel. Patients were assigned in a 1:1 ratio to thrombectomy plus medical
management (thrombectomy group) or medical management alone (control group). The
primary outcome was functional disability as measured by the shift in the
modified Rankin scale score (scale, 0 [no disability] to 6 [death]) at 90 days.
Violation of the proportional-odds assumption precluded the use of shift in the
modified Rankin scale score, so as prespecified, functional independence
(modified Rankin scale score of 0, 1, or 2) at 90 days was used as the primary
outcome. Safety outcomes were symptomatic intracranial hemorrhage and 90-day
mortality.
## Results
Among 280 patients in the thrombectomy group and 283 in the control
group, the median age was 71 years, the median NIHSS score was 10 (range, 3 to
36), and 42.8% were women; 36.6% received intravenous thrombolysis. Functional
independence at 90 days was seen in 58.6% of the patients in the thrombectomy
group and in 46.6% of those in the control group (adjusted rate ratio, 1.24; 95%
confidence interval, 1.07 to 1.44; Pā=ā0.004). The incidence of symptomatic
intracranial hemorrhage was 4.7% in the thrombectomy group and 2.2% in the
control group; 90-day mortality was 11.1% and 10.2%, respectively.
## Conclusions
Among patients with acute ischemic stroke due to medium-vessel
occlusion and moderate-to-severe deficits, thrombectomy led to a greater
likelihood of functional independence than medical management alone but also to
a higher risk of symptomatic intracranial hemorrhage. (Funded by the National
Natural Science Foundation of China and the Noncommunicable Chronic
Diseases-National Science and Technology Major Project; ORIENTAL-MeVO
ClinicalTrials.gov number, NCT06146790.).
---
DOI: 10.1056/NEJMoa2514120